As a successful outcome of the collaboration announced in 2023 between Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostic
As a successful outcome of the collaboration announced in 2023 between Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostic
/PRNewswire/ Progentec, a leader in next-gen diagnostics and digital technologies for the management of autoimmune diseases, announced today that Marc.
Bendcare Supports aiSLE™ DX Flare Risk Index Testing Access for Patients with Lupus (SLE)
News provided by
Share this article
OKLAHOMA CITY, April 8, 2021 /PRNewswire/
Progentec, a leader in diagnostic and digital technologies for the proactive management of autoimmune diseases, announced today that Bendcare, a large healthcare services and technology organization which empowers community rheumatologists in the United States, is supporting clinician and patient access to the aiSLE™ DX Flare Risk Index. Bendcare plans to begin offering rheumatologists in the Bendcare and American Arthritis and Rheumatology Associates (AARA) networks clinical education sessions focused on the laboratory technology later this month. Additionally, Progentec will be utilizing Bendcare s Columbus Data Repository to analyze the impact of the aiSLE™ DX Flare Risk Index.
Progentec Launches Care Management Platform for Lupus (SLE) Patients and Clinicians
News provided by
Share this article
OKLAHOMA CITY, Feb. 2, 2021 /PRNewswire/
Progentec, a leader in diagnostic and digital technologies for the proactive management of autoimmune diseases, announced today the launch of
(PRNewsfoto/Progentec Diagnostics, Inc.)
Systemic lupus erythematosus ( SLE or lupus ) is an extremely challenging disease to manage clinically. In fact, it has become a top 20 leading cause of death for young American women and disproportionately affects Black, Indigenous, and People of Color (BIPOC) communities. Challenges in achieving positive lupus health outcomes stem from the complex underlying biology of the autoimmune disease and the impact of social determinants of health (SDOH), specifically access to care and health literacy.